From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research

被引:0
作者
Cynthia L. Hsu
Rohit Loomba
机构
[1] University of California at San Diego,Division of Gastroenterology and Hepatology, Department of Medicine
[2] VA San Diego Healthcare System,Department of Medicine
[3] University of California at San Diego,MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine
[4] University of California at San Diego,The Herbert Wertheim School of Public Health and Human Longevity Science
来源
Nature Metabolism | 2024年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD), emphasizing the key metabolic factors of obesity, insulin resistance, vascular dysfunction and dyslipidaemia. Here, we discuss impacts on the existing body of clinical and preclinical liver disease research and on research moving forward.
引用
收藏
页码:600 / 602
页数:2
相关论文
共 50 条
[31]   Transitioning from NAFLD to MAFLD to MASLD in the Mexican population [J].
Priego-Parra, B. A. ;
Bernal-Reyes, R. ;
Icaza-Chavez, M. E. ;
Martinez-Vazquez, S. E. ;
Remes-Troche, J. M. .
REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2025, 90 (01) :153-156
[32]   Prognosis of MAFLD vs. NAFLD and implications for a nomenclature change [J].
Wong, Vincent Wai-Sun ;
Lazarus, Jeffrey, V .
JOURNAL OF HEPATOLOGY, 2021, 75 (06) :1267-1270
[33]   Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort [J].
Sanchez-Torres, Cristian ;
Tovar, Ana Ramirez ;
Chatman, Kelsey ;
Morris, Heather L. ;
Yu, Feng ;
Mospan, Andrea R. ;
Diehl, Anna Mae ;
Leung, Daniel H. ;
Viswanathan, Preeti ;
Squires, James E. ;
Palle, Sirish ;
Vos, Miriam B. .
HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
[34]   CHANGE IN NOMENCLATURE AND DEFINITION FROM NAFLD TO MASLD MAINTAINS THE DISEASE SEVERITY DETERMINING ASSOCIATION BETWEEN TYPE 2 DM AND MASLD - THE RESULTS OF MULTI-CENTRE INDIAN CONSORTIUM ON MASLD (ICOM-D) [J].
Duseja, Ajay ;
Choudhary, Narendra ;
De, Arka ;
Mehta, Manu ;
Singh, Shivaram ;
Anirvan, Prajna ;
Shalimar ;
Mukewar, Shrikant ;
Mukewar, Saurabh ;
Kar, Sanjib ;
Goyal, Omesh ;
Venkataraman, Jayanthi ;
Devadas, Krishnadas ;
Dixit, V. K. ;
Mehta, Varun ;
Maiwall, Rakhi ;
Ranjan, Piyush ;
Nagral, Aabha ;
Arora, Anil ;
Praharaj, Dibyalochan ;
Sharma, Brij ;
Valsan, Arun Koottumakkal ;
Dadhich, Sunil ;
Nijhawan, Sandeep ;
Roy, Akash ;
Padaki, Nagaraja Rao ;
Shukla, Akash ;
Asati, Pankaj ;
Gupta, Rohit ;
Saigal, Sanjiv ;
Narayanasamy, K. ;
Mehta, Rajiv ;
Bhattacharyya, Mallika ;
Prasad, V. G. ;
Koshy, Abraham ;
Alam, Seema ;
Sanyal, Arun .
HEPATOLOGY, 2024, 80 :S886-S887
[35]   Comparison of NAFLD, MAFLD, and MASLD Prevalence and Clinical Characteristics in Asia Adults [J].
Huang, Xinjuan ;
Yu, Ruoling ;
Tan, Xinyun ;
Guo, Manjie ;
Xia, Yuanqin ;
Zou, Huihui ;
Liu, Xuelian ;
Qin, Chunxiang .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
[36]   Cytochrome P450: New nomenclature and clinical implications [J].
Cupp, MJ ;
Tracy, TS .
AMERICAN FAMILY PHYSICIAN, 1998, 57 (01) :107-116
[37]   From NAFLD to MAFLD to MASLD: Looking for the Best Pediatric Label [J].
Iorio, Raffaele ;
Di Dato, Fabiola ;
Spagnuolo, Maria Immacolata .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05) :575-576
[38]   The new hepatic steatosis nomenclature. No more NAFLD! [J].
Castro-Narro, G. E. ;
Rinella, M. E. .
REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2024, 89 (02)
[39]   From NAFLD to MASLD - a new approach for the definition of fatty liver disease associated with metabolic dysfunction [J].
Gorczyca-Glowacka, Iwona ;
Nawacki, Lukasz ;
Dolecka-Slusarczyk, Magdalena ;
Ciba-Stemplewska, Agnieszka ;
Gluszek, Stanislaw .
MEDICAL STUDIES-STUDIA MEDYCZNE, 2025, 41 (01) :45-52
[40]   NAFLD vs MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)-Why the Need for a Change of Nomenclature? [J].
Gastaldelli, Amalia ;
Newsome, Philip N. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 (07) :e2407-e2410